January 08, 2018
Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer
Media
January 06, 2018
Nexstim enrols last patient in supplementary Phase III E-FIT trial
January 04, 2018
Targovax announces that ONCOS-102 generates immune activation in checkpoint inhibitor refractory melanoma patients
January 03, 2018
Altimmune Elects Mitchel Sayare, Ph.D. as Chairman of its Board of Directors
December 21, 2017
Altimmune Announces Positive Initial Data from Its HepTcell Phase 1 Study
December 18, 2017
Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer
December 14, 2017
WTX101 granted Fast Track designation by the U.S. FDA for the treatment of Wilson Disease
December 13, 2017
Strongbridge Biopharma plc Added to the NASDAQ Biotech Index
December 13, 2017
BONESUPPORT™ ACHIEVES AIM OF RECRUITING 136 PATIENTS INTO THE CERTiFy STUDY COMPARING CERAMENT®|BONE VOID FILLER WITH AUTOGRAFT
December 12, 2017
Orexo discloses more information about the improved market access position for Zubsolv® US in 2018